Find CMO/CDMOs that produce: Biologics
Recombinant Proteins
Category
Filters
Reset current filters
Selected filters:
Production region
Production scale
Qualifications
Follow us
CDMO-CMO
Jubilant Biosys
Recombinant Proteins production
Plants in:
Established in: 1998
Production scale:
small
medium
large
Employees: 1000
Facilities with global regulatory compliance
Customized and Flexible Collaboration Models
End-to-end drug discovery
All certificates
Replies quickly
CDMO-CMO
Catalent
Recombinant Proteins production
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CDMO-CMO
Shilpa Medicare Ltd
Recombinant Proteins production
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CMO
Resilience
Recombinant Proteins production
Innovative approach to biomanufacturing and complex biologics.
Cutting-edge technology for next-generation therapies.
Strong focus on accelerating the development of transformative medicines.
All certificates
Replies slower than most
CDMO-CMO
Boehringer Ingelheim Group
Recombinant Proteins production
Strong heritage in pharmaceutical innovation and biotechnology.
Comprehensive range of services from early development to commercial supply.
Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
CDMO-CMO
Argonaut Manufacturing Services Inc.
Recombinant Proteins production
Plants in:
Established in: 2016
Production scale:
medium
small
Low Volume high value API Fill and Finish Service
In-line monitoring, SKAN Isolators, Highly Experienced Staff
Capacity Available, Ready for your API
All certificates
Replies quickly
CDMO-CMO
KBI Biopharma
Recombinant Proteins production
Plants in:
Established in: 1996
Production scale:
large
small
medium
Leading in biopharmaceutical development and biologic API production.
Comprehensive services from cell line development to commercial manufacturing.
Strong track record in delivering complex and high-quality biologics.
All certificates
Contact supplier
Not active
Looking for CMO/CDMO Services?
Find a list of providers specializing in CMOs/CDMOs Services for Recombinant Proteins. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
CMO/CDMO - Contract (Development) Manufacturing Organizations
CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.
Biologics
Biologics CMOs/CDMOs specialize in the manufacturing and development of biopharmaceutical products, which are typically derived from living organisms or biological sources such as proteins, antibodies, vaccines, and cell therapies.
Recombinant Proteins
Recombinant proteins, produced through genetic engineering, are pivotal in targeted therapies. Their manufacturing in bioreactors requires precise control of conditions to ensure product purity, potency, and safety, addressing various therapeutic conditions.
Pharmaoffer features a range of Contract Development and Manufacturing Organizations (CDMOs) with expertise in the production of recombinant proteins. These proteins, produced through advanced genetic engineering techniques, are essential in the development of targeted therapies, including Recombinant Protein Production and Recombinant Protein Manufacturing.
Key Services Provided by Our Listed CDMOs:
Advanced Bioreactor Technology: Utilization of state-of-the-art bioreactors with precise control over environmental conditions to optimize protein expression and quality. This is a crucial aspect of protein expression service.
Product Purity and Potency: Emphasis on achieving high levels of product purity and potency, essential for the efficacy of recombinant protein therapies. This includes specialized recombinant protein service.
Quality Assurance and Safety: Rigorous quality control measures to ensure the safety, stability, and efficacy of recombinant proteins. This is a key component of recombinant protein synthesis.
Custom Protein Expression: Tailored approaches to recombinant protein production, including the use of various expression systems to meet specific therapeutic needs.
Comprehensive Development Services: From gene cloning and protein expression to purification and final product formulation, offering end-to-end development services for recombinant proteins.
Your Partner in Advanced Protein Therapies
On Pharmaoffer, you can connect with CDMOs that specialize in the development and manufacturing of recombinant proteins. Our platform ensures you have access to cutting-edge technology and expertise, essential for advancing new treatments in various therapeutic areas.
